RICC A/S: Financial statements 2015
CVR: 20690003
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
RICC A/S (CVR 20690003) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 174,279,000 and a net result of DKK 1,229,520,000 compared with DKK -5,462,000 the year before. That is an increase of 26.1% compared with the year before. Equity in the 2015 report amounted to DKK 211,537,000. The solvency ratio was 53.4%.
- Gross Profit
- DKK 174,279,000
- Profit/Loss
- DKK 1,229,520,000
- Equity
- DKK 211,537,000
- Total Assets
- DKK 395,859,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 174.3 mio. | 1.2 mia. | 211.5 mio. | - |
| 2014 | - | 138.2 mio. | -5.5 mio. | -68 mio. | - |
Official annual report
How creditworthy is RICC A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
RICC A/S has published its annual report for 2014. Gross profit came to DKK 138,204,000, and the net result was DKK -5,462,000.
About RICC A/S
RICC A/S is a Danish company of the type Aktieselskab based in København V, founded in 1998. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ROCHE INNOVATION CENTER COPENHAGEN A/S and SANTARIS PHARMA A/S. The management consists of Carole Hassoun. The board consists of Sylke Pöhling (chair), Carole Hassoun and Isabel Marianne Joerin. The company is owned by F. Hoffmann-La Roche Ltd. The company has 1 employee (2024). In 2025, the company reported a gross profit of DKK 91,000 and a net result of DKK 160,586,000 compared with DKK 730,000 the year before. Equity in the 2025 report amounted to DKK 163,015,000.